Gaëtan Deslée (Gaëtan Deslee)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Epidermal Growth Factor Receptor

Brain Metastases

Top Venues

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Emma Loeffler, Julien Ancel, Véronique Dalstein, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby
HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies. Life (Basel, Switzerland) 14 (1) (2023)
Emma Loeffler, Julien Ancel, Véronique Dalstein, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby
HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies. Life (Basel, Switzerland) 14 (1) (2023)
Emma Loeffler, Julien Ancel, Véronique Dalstein, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby
HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies. Life (Basel, Switzerland) 14 (1) (2023)
Youssef Lamkouan, Sandra Dury, Jeanne Marie Perotin, Remi Picot, Anne Durlach, Olivier Passouant, Sebastian Sandu, Maxime Dewolf, Antoine Dumazet, François Lebargy, Gaëtan Deslée, Claire Launois
Acute severe idiopathic lymphoid interstitial pneumonia: A case report. Medicine 99 (30) (2020)
Julien Ancel, Philippe Birembaut, Maxime Dewolf, Anne Durlach, Béatrice Nawrocki-Raby, Véronique Dalstein, Gonzague Delepine, Silvia Blacher, Gaëtan Deslée, Christine Gilles, Myriam Polette
Programmed Death-Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC. Cancers 11 (10) (2019)